ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
Dow Jones
38.675,68
1,18%
Euro vs US Dollar
1,07725
0,00%
Bitcoin
63.048,05
-1,32%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Edge Therapeutics, Inc. (EDGE)

  7. Edge Therapeutics, Inc. (EDGE) News

EDGE

EDGE THERAPEUTICS, INC. (EDGE)

Edge Therapeutics, Inc.
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:EDGE
DatumZeitQuelleÜberschriftSymbolFirma
18/03/201923h01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:EDGEEdge Therapeutics, Inc.
18/03/201922h59Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:EDGEEdge Therapeutics, Inc.
18/03/201922h57Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:EDGEEdge Therapeutics, Inc.
18/03/201922h54Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:EDGEEdge Therapeutics, Inc.
18/03/201922h52Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:EDGEEdge Therapeutics, Inc.
18/03/201922h49Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:EDGEEdge Therapeutics, Inc.
18/03/201922h46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:EDGEEdge Therapeutics, Inc.
18/03/201922h44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:EDGEEdge Therapeutics, Inc.
18/03/201922h40Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:EDGEEdge Therapeutics, Inc.
18/03/201922h38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:EDGEEdge Therapeutics, Inc.
18/03/201922h35Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:EDGEEdge Therapeutics, Inc.
18/03/201912h31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EDGEEdge Therapeutics, Inc.
15/03/201922h13Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EDGEEdge Therapeutics, Inc.
08/03/201923h24Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EDGEEdge Therapeutics, Inc.
04/03/201923h30Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:EDGEEdge Therapeutics, Inc.
04/03/201923h29Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EDGEEdge Therapeutics, Inc.
04/03/201923h25Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:EDGEEdge Therapeutics, Inc.
25/02/201923h03Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:EDGEEdge Therapeutics, Inc.
22/02/201923h23Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:EDGEEdge Therapeutics, Inc.
21/02/201922h21Edgar (US Regulatory)Annual Report (10-k)NASDAQ:EDGEEdge Therapeutics, Inc.
21/02/201921h36Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:EDGEEdge Therapeutics, Inc.
21/02/201912h33Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EDGEEdge Therapeutics, Inc.
21/02/201912h15GlobeNewswire Inc.Edge Therapeutics Announces Full Year 2018 Financial ResultsNASDAQ:EDGEEdge Therapeutics, Inc.
15/02/201920h35Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:EDGEEdge Therapeutics, Inc.
15/02/201912h09Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:EDGEEdge Therapeutics, Inc.
13/02/201917h02Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:EDGEEdge Therapeutics, Inc.
11/02/201917h18Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:EDGEEdge Therapeutics, Inc.
04/02/201923h11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EDGEEdge Therapeutics, Inc.
04/02/201923h10Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:EDGEEdge Therapeutics, Inc.
30/01/201923h29Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EDGEEdge Therapeutics, Inc.
 Showing the most relevant articles for your search:NASDAQ:EDGE

Kürzlich von Ihnen besucht

AMEX
XLF
Financial Select Sector
NYSE
MRK
Merck
CCOM
US30
US 30
TG
MBG
MercedesBenz
COIN
ETHUSD
Ethereum
CCOM
SILVER
SILVER
DBI
MDAX
MDAX
USOTC
ADDYY
Adidas (QX)
TG
BAS
BASF
NASDAQ
QQQ
Invesco QQQ Trust Series 1
FX
EURJPY
Euro vs Yen
TG
TUI1
Tui
NYSE
XOM
Exxon Mobil
DBI
TDXP
Tec DAX
TG
DBK
Deutsche Bank
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten